Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Aug;112(4):317-38.
doi: 10.1016/j.ymgme.2014.04.007. Epub 2014 May 9.

Pleiotropic genes for metabolic syndrome and inflammation

Aldi T Kraja  1 Daniel I Chasman  2 Kari E North  3 Alexander P Reiner  4 Lisa R Yanek  5 Tuomas O Kilpeläinen  6 Jennifer A Smith  7 Abbas Dehghan  8 Josée Dupuis  9 Andrew D Johnson  10 Mary F Feitosa  11 Fasil Tekola-Ayele  12 Audrey Y Chu  13 Ilja M Nolte  14 Zari Dastani  15 Andrew Morris  16 Sarah A Pendergrass  17 Yan V Sun  18 Marylyn D Ritchie  19 Ahmad Vaez  20 Honghuang Lin  21 Symen Ligthart  22 Letizia Marullo  23 Rebecca Rohde  24 Yaming Shao  25 Mark A Ziegler  26 Hae Kyung Im  27 Cross Consortia Pleiotropy GroupCohorts for Heart andAging Research in Genetic EpidemiologyGenetic Investigation of Anthropometric Traits ConsortiumGlobal Lipids Genetics ConsortiumMeta-Analyses of GlucoseInsulin-related traits ConsortiumGlobal BPgen ConsortiumADIPOGen ConsortiumWomen's Genome Health StudyHoward University Family StudyRenate B Schnabel  28 Torben Jørgensen  29 Marit E Jørgensen  30 Torben Hansen  31 Oluf Pedersen  32 Ronald P Stolk  33 Harold Snieder  34 Albert Hofman  35 Andre G Uitterlinden  36 Oscar H Franco  37 M Arfan Ikram  38 J Brent Richards  39 Charles Rotimi  40 James G Wilson  41 Leslie Lange  42 Santhi K Ganesh  43 Mike Nalls  44 Laura J Rasmussen-Torvik  45 James S Pankow  46 Josef Coresh  47 Weihong Tang  48 W H Linda Kao  49 Eric Boerwinkle  50 Alanna C Morrison  51 Paul M Ridker  52 Diane M Becker  53 Jerome I Rotter  54 Sharon L R Kardia  55 Ruth J F Loos  56 Martin G Larson  57 Yi-Hsiang Hsu  58 Michael A Province  59 Russell Tracy  60 Benjamin F Voight  61 Dhananjay Vaidya  62 Christopher J O'Donnell  63 Emelia J Benjamin  64 Behrooz Z Alizadeh  65 Inga Prokopenko  66 James B Meigs  67 Ingrid B Borecki  68
Affiliations
Meta-Analysis

Pleiotropic genes for metabolic syndrome and inflammation

Aldi T Kraja et al. Mol Genet Metab. 2014 Aug.

Abstract

Metabolic syndrome (MetS) has become a health and financial burden worldwide. The MetS definition captures clustering of risk factors that predict higher risk for diabetes mellitus and cardiovascular disease. Our study hypothesis is that additional to genes influencing individual MetS risk factors, genetic variants exist that influence MetS and inflammatory markers forming a predisposing MetS genetic network. To test this hypothesis a staged approach was undertaken. (a) We analyzed 17 metabolic and inflammatory traits in more than 85,500 participants from 14 large epidemiological studies within the Cross Consortia Pleiotropy Group. Individuals classified with MetS (NCEP definition), versus those without, showed on average significantly different levels for most inflammatory markers studied. (b) Paired average correlations between 8 metabolic traits and 9 inflammatory markers from the same studies as above, estimated with two methods, and factor analyses on large simulated data, helped in identifying 8 combinations of traits for follow-up in meta-analyses, out of 130,305 possible combinations between metabolic traits and inflammatory markers studied. (c) We performed correlated meta-analyses for 8 metabolic traits and 6 inflammatory markers by using existing GWAS published genetic summary results, with about 2.5 million SNPs from twelve predominantly largest GWAS consortia. These analyses yielded 130 unique SNPs/genes with pleiotropic associations (a SNP/gene associating at least one metabolic trait and one inflammatory marker). Of them twenty-five variants (seven loci newly reported) are proposed as MetS candidates. They map to genes MACF1, KIAA0754, GCKR, GRB14, COBLL1, LOC646736-IRS1, SLC39A8, NELFE, SKIV2L, STK19, TFAP2B, BAZ1B, BCL7B, TBL2, MLXIPL, LPL, TRIB1, ATXN2, HECTD4, PTPN11, ZNF664, PDXDC1, FTO, MC4R and TOMM40. Based on large data evidence, we conclude that inflammation is a feature of MetS and several gene variants show pleiotropic genetic associations across phenotypes and might explain a part of MetS correlated genetic architecture. These findings warrant further functional investigation.

Keywords: Inflammatory markers; Meta-analysis; Metabolic syndrome; Pleiotropic associations; Regulome.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

All authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Prevalence of MetS and its components and mean levels of inflammatory markers in individuals classified with and without MetS (M1 vs. M0). Footnote: Top histogram numbers represent prevalence (%) of MetS, T2D and MetS components. Bottom numbers represent number of participants for a particular trait. The inflammatory marker boxplot graph comparisons were built by using “rnorm” function in R with mean, standard deviation and sample size corresponding to subgroups with and without MetS from original (B) data. Overall, they represent 53 tests of inflammatory markers per MetS strata, summarized in Supplemental Figures 1(a–g). The number within each pair of boxplots marked by “D=” is the difference of two means of an inflammatory marker in groups of participants classified with versus without MetS. The light yellow boxed number at the bottom of the same graph marked with “pt=” represents a p-value calculated by pooled t-test for testing if their means (M1 vs. M0) are different. In case the color of pt-value box is gray, then the p-value does not pass the Bonferroni threshold p=9.43e-04.
Figure 2
Figure 2
A network of 25 pleiotropic genes with putative contributions to MetS, including inflammation. Footnote: In the figure they connect by GWAS phenotypic evidence and whether selected SNPs show any regulatory features based on the ENCODE database as implemented via HaploReg [50]/RegulomeDB [51] software. All phenotypic labels correspond to associations reported in the Results, Discussion, Table 5 and Suppplemental Table 5.

References

    1. Grundy SM, Hansen B, Smith SC, Jr, Cleeman JI, Kahn RA. A. American Heart, L. National Heart, I. Blood, A. American Diabetes, Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109:551–556. - PubMed
    1. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. The American journal of medicine. 2006;119:812–819. - PubMed
    1. Monda KL, North KE, Hunt SC, Rao DC, Province MA, Kraja AT. The genetics of obesity and the metabolic syndrome. Endocrine, metabolic & immune disorders drug targets. 2010;10:86–108. - PMC - PubMed
    1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428. - PubMed
    1. Lusis AJ, Attie AD, Reue K. Metabolic syndrome: from epidemiology to systems biology. Nature reviews. Genetics. 2008;9:819–830. - PMC - PubMed

Publication types

Grants and funding